Literature DB >> 30097271

iRhom2 promotes atherosclerosis through macrophage inflammation and induction of oxidative stress.

Cheng Chaohui1, Huang Wei1, Wen Hongfeng2, Zhang Yueliang1, Peng Xiaoqin1, Zhou Pingli1, Ai Zhibing3.   

Abstract

Atherosclerosis is a complex chronic inflammatory disease that is characterized by the formation of lipid-rich plaques on the inner walls of the arteries. Inactive rhomboid protein 2 (iRhom2) was recently determined as a necessary regulator for the shedding of tumor necrosis factor-alpha (TNF-α) in immune cells. In the present study, we aimed to explore the effects of iRhom2 on the inflammatory response and oxidative stress induced by low-density lipoprotein (ox-LDL) in RAW264.7 and THP-1-derived macrophages. The expression levels of iRhom2 were also investigated in apolipoprotein E knockout (ApoE-/-) mice fed a high-fat diet (HFD). iRhom2 was significantly induced by ox-LDL in macrophages, as confirmed by Western blotting and RT-qPCR analysis. Furthermore, iRhom2 knockdown showed significant suppressive effects on the activation of ox-LDL-induced RAW264.7 and THP-1-derived macrophages through reducing TACE and TNFR2 expressions, and the inactivation of the IκBα/NF-κB signaling pathway. A reduction in reactive oxygen species (ROS) generation, malondialdehyde (MDA) levels, and nitric oxide (NOX) activity and an increase in glutathione peroxidase (GSH-Px) activity were determined in the absence of iRhom2 expression. In addition, the NF-E2 related factor-2 (Nrf-2)/heme oxygenase-1 (HO-1) pathway was also upregulated in ox-LDL-treated macrophages subjected to iRhom2 inhibition. Moreover, suppression of iRhom2 expression inactivated PI3K/AKT pathway activation, contributing to ROS reduction in ox-LDL-stimulated macrophages. iRhom2 was also significantly expressed in ApoE-/- mice fed HFD. Finally, we observed increased serum levels of TNF-α, TNFR1, and TNFR2 in patients with coronary artery atherosclerosis as compared to healthy volunteers. In conclusion, our findings suggested that iRhom2 played a key role in the pathogenesis of atherosclerosis, and that iRhom2 might be a potential therapeutic target against atherosclerosis.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; Inflammation; Macrophages; Oxidative stress; iRhom2

Mesh:

Substances:

Year:  2018        PMID: 30097271     DOI: 10.1016/j.bbrc.2018.07.133

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Ageing- and AAA-associated differentially expressed proteins identified by proteomic analysis in mice.

Authors:  Jinrui Ren; Jianqiang Wu; Xiaoyue Tang; Siliang Chen; Wei Wang; Yanze Lv; Lianglin Wu; Dan Yang; Yuehong Zheng
Journal:  PeerJ       Date:  2022-05-25       Impact factor: 3.061

2.  Deficiency of inactive rhomboid protein 2 (iRhom2) attenuates diet-induced hyperlipidaemia and early atherogenesis.

Authors:  Carmen Hannemann; Johannes H Schecker; Alica Brettschneider; Jana Grune; Nicole Rösener; Andrea Weller; Verena Stangl; Edward A Fisher; Karl Stangl; Antje Ludwig; Bernd Hewing
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 3.  The Role of iRhom2 in Metabolic and Cardiovascular-Related Disorders.

Authors:  Ramasatyaveni Geesala; Priya D Issuree; Thorsten Maretzky
Journal:  Front Cardiovasc Med       Date:  2020-11-24

4.  Relationship between Serum FGF21 and vWF Expression and Carotid Atherosclerosis in Elderly Patients with Hypertension.

Authors:  Jing Bian; Lairong Chen; Qin Li; Yunfeng Zhao; Delu Yin; Shanhong Sun
Journal:  J Healthc Eng       Date:  2022-02-22       Impact factor: 2.682

5.  Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells.

Authors:  Anja Adelina Giese; Aaron Babendreyer; Stefan Düsterhöft; Andreas Ludwig; Peter Krappen; Annika Gross; Pavel Strnad
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

Review 6.  iRhom2: An Emerging Adaptor Regulating Immunity and Disease.

Authors:  Mazin A Al-Salihi; Philipp A Lang
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.